Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, August 19 at 2:00 PM EDT

Register Free →

Search

Top

Back to Contracts

Infectious Disease Vaccine Development

Active

Federal

Response Deadline10/30/2026, 04:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract pertains to the development of vaccines for infectious diseases under the auspices of the Defense Health Agency, part of the Department of Defense, with a primary focus on advancing medical preparedness for threats to military and public health. The solicitation is structured as a subcontract and is governed under NAICS code 325413, which specifically relates to pharmaceutical and medicine manufacturing. Proposals must be submitted by the deadline of October 30, 2026, and performance is expected to center in Frederick, though no other geographic details are specified. Certain areas of infectious disease research are explicitly excluded from consideration under this solicitation, narrowing the scope to specific pathogen targets or technological approaches relevant to defense health priorities. No set-aside provisions or organizational type restrictions are outlined, and no point of contact is listed, requiring interested parties to refer to the official SAM.gov link for further submission guidelines and technical requirements.

General Info

Vaccine development contract for Defense Health Agency, deadline October 30, 2026, focused on specific infectious disease threats.

Agency

Department Of Defense → Defense Health AgencyView Agency

NAICS

325413 - In-Vitro Diagnostic Substance ManufacturingView NAICS

Place of Performance

Frederick, MD, USA

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PostedAug 7

subcontract

Response DeadlineOct 30

Submission deadline

Response Deadline

10/30/2026, 04:00:00 PM UTCin 3 months

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDepartment Of Defense → Defense Health Agency

ContactsNo contacts available

OfficeN/A

Organization / Agency

Department Of Defense → Defense Health Agency

View Agency Profile

Office AddressN/A

ContactsNo contact information available

Full Description

Show more

Development of vaccines for infectious diseases; currently excluded in certain focus areas under this solicitation.

Similar Contracts

Same NAICS industry code

6550--DIASORIN - 6 MONTH BRIDGE

Solicitation # 36C26226Q1269

The contract titled “6550--DIASORIN - 6 MONTH BRIDGE” is a special notice issued by the Department of Veterans Affairs through the 262-NETWORK Contract Office 22 (36C262), with the solicitation number 36C26226Q1269. It was posted on August 7, 2026, with a response deadline of August 17, 2026, at 7:00 PM Eastern Time. The NAICS code 325413 indicates the contract relates to pharmaceutical and biological product manufacturing. The office responsible for this procurement is located in Gilbert, Arizona, 85297, and the primary point of contact is Contract Specialist Rebecca Gaba, reachable via email at Rebecca.Gaba@va.gov. This is a short-term bridge agreement with a duration of six months, likely intended to maintain continuity in critical supply chains or services. There is no specified set-aside type, and the place of performance details are not provided, suggesting that the work may be performed remotely or across multiple locations without geographic restriction.

262-NETWORK Contract Office 22 (36C262)

POSTED

about 20 hours ago

DEADLINE

6550--Blood Bank Reagents - New Base Plus Four Option Year Contract

Solicitation # 36C24526Q0650

The contract solicitation titled Blood Bank Reagents - New Base Plus Four Option Year Contract under solicitation number 36C24526Q0650 is issued by the Department of Veterans Affairs through the 245-NETWORK Contract Office 5 located in Linthicum, Maryland. It seeks qualified vendors to supply blood bank reagents with a base period and the potential for four additional option years, extending the overall performance window. The place of performance is designated as Huntington, West Virginia, with deliveries and services expected to meet the operational needs of Veterans Affairs medical facilities in that region. The solicitation is classified as a combined action and is not restricted to any specific small business set-aside category. All proposals must be submitted via email to Zachary Altner at Zachary.Altner@va.gov no later than August 10, 2026, at 10:00 A.M. EST. The solicitation was posted on July 14, 2026, and is governed under NAICS code 325413, which pertains to biological product manufacturing. Zachary Altner serves as the primary point of contact for inquiries and submissions, with a direct phone number provided for communication. Interested parties are directed to the official SAM.gov link for full details and documentation related to the requirements, evaluation criteria, and submission instructions.

245-NETWORK Contract Office 5 (36C245)

POSTED

DEADLINE

Medical Diagnostic Test Kit ManufacturingThe contract pertains to the manufacture of iron-related bacteria test kits, encompassing the formulation of reagents, preparation of chemical components, and assembly of all test kit elements tailored to meet strict technical specifications set by the Department of Defense. The work must be performed in compliance with detailed DLA requirements to ensure accuracy, reliability, and consistency in diagnostic outcomes for military and medical applications. The project falls under NAICS code 325413, indicating it involves the manufacturing of laboratory apparatus and reagents, and is structured as a subcontract within the Medical Supply Chain MD Surg FSF framework. Performance is located in Suffolk, Virginia, with a zip code of 23435-5000, and all materials and processes must adhere to the specified quality and operational standards outlined by the agency. The solicitation was posted on August 5, 2026, with responses due by August 11, 2026, placing a tight window for qualified vendors to submit proposals. While the solicitation number is SPE2DS26T314H and further details are accessible via the DIBBS portal, no set-aside provisions or specific organization type designations are indicated, meaning the opportunity is open to eligible subcontractors regardless of size or certification status, provided they can meet the technical and logistical demands of the task.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

CONTROL, RESPIRATORY PA

Solicitation # SPE2DS-26-T-311F

The BioFire RP2.1/RP2.1plus Control Panel is a synthetic nucleic acid-based quality control product consisting of 12 vials, each containing 300 microliters of a non-infectious buffer solution with stabilizers and preservatives. It is designed for in vitro use with the FilmArray instrument to monitor the detection and identification of respiratory pathogens during RP2.1 panel testing. Each kit provides sufficient reagent for six quality control runs, including six positive and six negative controls. The product requires strict frozenstorage between -25°C and -15°C (-13°F to 5°F) and has a non-extendable shelf life of 18 months, with no more than two months allowed to have passed from the date of manufacture to delivery to the government. Labeling must include the date of manufacture, expiration date, contract number, and lot number in compliance with Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must meet commercial standards, ensuring protection against damage, with exterior containers suitable for safe transport at the lowest cost to the specified delivery point. The item is governed by DLA technical and packaging requirements, including RS013 for shelf life, RP001 for packaging standards, and RD003 for potential covered defense information. The National Stock Number is 6550-01-690-4435, with a procurement quantity of three kits under solicitation SPE2DS-26-T-311F, with a delivery deadline of 83 days after award.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

TEST KIT, CORONAVIRUS D

Solicitation # SPE2DS-26-T-314C

The contract is for the procurement of Abbott BinaxNOW COVID-19 Antigen Self Tests, intended for over-the-counter, at-home use, with each kit containing two tests and sold in cases of twelve kits. The product must be stored between 2 and 30 degrees Celsius and is subject to strict shelf-life requirements: it must have a non-extendable shelf life of exactly twelve months, with no more than one month having elapsed from the date of manufacture to the date of delivery to the government. All packaging and labeling must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and must clearly indicate the date of manufacture, expiration date, and the contract or lot number. Packaging must be commercial grade, sealed to protect contents from damage, and shipped in suitable exterior containers to ensure safe, cost-effective delivery via common carriers to the designated delivery point in FPO with a required delivery time of five days. The item is identified by NSN 6550-01-716-1573 and falls under solicitation SPE2DS-26-T-314C, issued by the Department of Defense’s Medical Supply Chain for military use. Technical and quality requirements referenced in the contract are governed by the DLA Master List, and the acquisition includes provisions for covered defense information and removal of government identification from non-accepted supplies.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

TEST KIT, BACTERIA DETE

Solicitation # SPE2DS-26-T-314H

The contract is for a bacterial determination test kit specifically designed for iron-related bacteria, supplied in packages of nine units per PG. It is subject to stringent technical and quality requirements governed by the DLA Master List, with compliance controlled by the revision in effect at the time of solicitation or award. The item is classified as a TYPE I (CODE M) medical product with a fixed 24-month shelf life that is non-extendable, requiring no more than three months to have elapsed from the date of manufacture to delivery. All packaging must comply with the Medical Marking Standard No. 1, including clear labeling with the date of manufacture, expiration or retest date, and the contract or lot number. The product must be stored and transported at refrigerated temperatures between 2 and 8 degrees Celsius and kept in a vertical orientation. Hazardous communication standards apply, obligating suppliers to provide Safety Data Sheets and labels compliant with OSHA’s revised Hazard Communication Standard aligned with the Globally Harmonized System, and to train employees on these requirements. The item’s NSN is 6550-01-719-0829, and delivery is required within five days of award. The solicitation number is SPE2DS-26-T-314H, with a bid deadline of August 11, 2026, and the procurement is managed by the Department of Defense’s Medical Supply Chain under the U.S. Defense Logistics Agency.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Medical Device Packaging and Kit AssemblyThe contract entails the final assembly, sterilization, labeling, and packaging of epidural anesthesia sets into compliant medical kits following strict Department of Defense standards, specifically MIL-STD-2073-1E and MIL-STD-129, ensuring full adherence to DLA requirements for medical device packaging and kit assembly. The work must be executed with precision to meet military-grade specifications for functionality, sterility, and documentation, with all kits intended for use in medical supply chains under the Department of Defense. The place of performance is designated as APO with ZIP code 09094-3219, indicating the work will be conducted at a military logistics or overseas support location. The opportunity is classified as a subcontract with a NAICS code of 325413, which corresponds to the manufacturing of medical and dental instruments and supplies. The solicitation was posted on August 4, 2026, with a response deadline of August 10, 2026, indicating a narrow window for submission and requiring rapid mobilization of resources and compliance readiness. The contract falls under the purview of the Medical Supply Chain MD Surg FSF within the Department of Defense, emphasizing its critical role in supporting surgical readiness and medical operational capabilities. All activities must align with federal procurement protocols and ensure traceability, quality control, and regulatory compliance throughout the entire packaging and kit assembly process.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

TEST KIT, CORONAVIRUS D

Solicitation # SPE2DS-26-T-308W

The contract is for the procurement of 150,000 units of the QuickVue At-Home OTC COVID-19 Test kit, a rapid antigen detection system designed for self-administration using an anterior nasal swab. Each kit contains all necessary components for two tests, including a tube holder, two prefilled extraction tubes, two swabs, and two test strips with a dipstick format that delivers results in ten minutes through a two-color readout: a blue control line and a red test line. The test is intended for single-user administration, with the two tests in each kit to be performed 24 to 36 hours apart, eliminating the need for additional equipment or laboratory support. Built-in procedural controls ensure test validity, and all materials are pre-assembled for immediate use. The kits are to be delivered within 20 days of award under solicitation SPE2DS-26-T-308W, issued by the Department of Defense’s Medical Supply Chain MD Surg FSF, with performance specified to occur in West Los Angeles, CA. The contract includes adherence to DLA technical and quality requirements under RA001, packaging standards per RP001, and removal protocols for government identification on non-accepted items per RQ011, with the NSN 6550-01-697-6662 identifying the product for federal acquisition purposes.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

CONTROL SET, GLUCOSE

Solicitation # SPE2DS-26-T-308J

The control set for glucose is designed for use with the Accu-Chek Inform II system and includes two 2.5 mL vials—one each of Level 1 and Level 2 control solutions—to ensure accurate calibration and performance verification of test strips. It must be stored between 39 and 86 degrees Fahrenheit (4 to 30 degrees Celsius) and must not be frozen. The item is issued as a single unit and is subject to strict medical procurement standards, including commercial packaging requirements that ensure protection from damage and safe delivery by common carriers. All units must be marked in accordance with Medical Marking Standard No. 1, which supersedes MIL-STD-129, and include the date of manufacture, expiration or retest date, contract number, and lot number. The item has a non-extendable shelf life of 24 months, and no more than three months may have elapsed from the date of manufacture to the date of government delivery. Technical and quality requirements referenced under R and I numbers are governed by the DLA Master List, with revision standards tied to solicitation or award dates depending on acquisition size. This item is classified as a Type I (Code M) medical supply, and all labeling, packaging, and marking must comply with the latest version of MMS1C. The NSN is 6550-01-642-5011, the solicitation number is SPE2DS-26-T-308J, and delivery is required within 20 days after order award to Fort Campbell, with the contract managed by the Department of Defense under the Medical Supply Chain.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Fisher Scientific Reagents and Consumable Materials for Cell Therapy Manufacturing

Solicitation # 26-008155

The National Institutes of Health Clinical Center plans to award a sole-source firm-fixed-price purchase order to Fisher Scientific for validated reagents and consumable materials essential to the manufacturing of FDA-regulated cell-based therapies used in NIH clinical trials. These materials have been rigorously validated and approved by the Center for Cellular Engineering’s Quality Assurance Department to ensure consistent quality, safety, and efficacy in producing cell therapies for patient care. Any substitution of these materials would necessitate extensive and costly revalidation of manufacturing processes, leading to significant delays and potential risks to ongoing clinical trials, making Fisher Scientific the only viable supplier capable of providing the required validated products and supporting documentation compliant with federal regulatory standards. The acquisition is authorized under FAR 13.106-1(b)(1)(i), which allows for single-source procurement when only one provider can meet the government’s specific requirements, and the value does not exceed the simplified acquisition threshold. The product service code is 6550, and the NAICS code is 325413, classifying the items as in-vitro diagnostic substances. Performance will occur at the NIH Clinical Center in Bethesda, Maryland. While this notice does not solicit bids or proposals, responsible parties may submit capability statements by August 13, 2026, at 6:00 p.m. Eastern Time, referencing POTS 26-008155, though the government retains full discretion to proceed without competition. All inquiries should be directed to Shasheshe Goolsby of the Hospital and Laboratory Support Division.

National Institutes Of Health Olao

POSTED

DEADLINE

CryoStor® CS10, 100 mL Bags for Cell Therapy Manufacturing

Solicitation # 26-007655

The National Institutes of Health Clinical Center plans to award a sole-source firm-fixed-price purchase order to BioLife Solutions for 80 bags of CryoStor® CS10, 100 mL, used exclusively for cryopreserving cell therapy products in FDA-regulated clinical trials. The product is essential to the Center for Cellular Engineering’s manufacturing processes, having been rigorously validated and approved by quality assurance to ensure the safety and consistency of therapies administered to patients. Substituting an alternative cryoprotectant would necessitate extensive revalidation, leading to significant delays, increased costs, and potential disruption to patient care. CryoStor® CS10 is the only commercial cryoprotectant with an FDA Master File and is the only product fully qualified for use in the NIH’s regulated environment, justifying the sole-source designation under FAR 13.106-1(b)(1)(i). The acquisition supports critical clinical research operations at the NIH Clinical Center in Bethesda, Maryland, under PSC 6550 and NAICS 325413. While the notice does not request formal proposals, responsible parties may submit capability statements by August 13, 2026, though the government reserves the right to proceed without competition. All submissions must reference solicitation number 26-007655 and be sent electronically to Shasheshe Goolsby at the NIH Office of Acquisitions and Logistics Management.

National Institutes Of Health Olao

POSTED

DEADLINE

CHIP, HYDROGEN PEROX

Solicitation # SPE2DS-26-T-300S

The contract under solicitation SPE2DS-26-T-300S is for the procurement of one unit of CHIP, HYDROGEN PEROXIDE for use with a CMS analyzer, featuring ten measurement capillaries filled with a substance-specific reagent detection system calibrated to a measuring range of 0.20–2.0 ppm and capable of conducting ten tests. The procurement is managed by the Defense Logistics Agency under the Department of Defense, with a response deadline of August 10, 2026, and a posted date of August 3, 2026. Delivery is required at Camp Carroll, Waegwan, Korea, under FOB Destination terms, with the item to be delivered within 84 calendar days of the request issue date, resulting in an anticipated delivery window ending around October 27, 2026. The contract specifies a fixed-price structure with no option quantities indicated, and while individual unit pricing is listed at $122.00, the total contract value cannot be determined due to incomplete pricing details. Compliance with stringent packaging and marking standards is mandatory, governed by MIL-STD-2073-1E and the Medical Marking Standard No. 1, which supersedes MIL-STD-129 for medical items. Labels must include the date of manufacture, expiration or retest date, contract number, and lot number, with hazardous material labeling adhering to the Hazard Communication Standard and specific submission requirements for hazard warning labels and material safety data sheets prior to award. The contractor must use Wide Area WorkFlow for electronic invoicing and receiving reports, and the government conducts all inspection and acceptance at the delivery point. Numerous FAR and DFARS clauses are incorporated, including those on employment eligibility verification, combating human trafficking, sustainable products, safeguarding contractor information systems, and NIST SP 800-171 compliance, some with deviations allowing for modified application. Offerors must hold a valid Unique Entity ID and CAGE code, submit socioeconomic status representations, and disclose any covered defense telecommunications equipment or joint venture partnerships. All proposals must be submitted electronically via DIBBS, and no physical attachments or formal evaluation factors are specified beyond implicit Low Price Technically Acceptable considerations typical of simplified acquisitions.

Defense Logistics Agency

POSTED

DEADLINE

More opportunities from Department Of Defense → Defense Health Agency

Same awarding agency

Emergency Bulk Gas Delivery ServicesThe contract mandates on-call emergency delivery of liquid oxygen to Landstuhl Regional Medical Center with a strict four-hour response window to avert life-threatening supply shortages. Services must be available around the clock to ensure uninterrupted medical operations, particularly in urgent care and critical care scenarios where oxygen is essential. The contractor is expected to maintain immediate operational readiness, including properly maintained equipment, trained personnel, and contingency plans to meet response time obligations regardless of weather, logistical challenges, or other disruptions. This subcontract falls under NAICS code 484220 for specialized freight trucking and is issued by the Defense Health Agency under the Department of Defense. The place of performance is exclusively at Landstuhl, Germany, with a ZIP code of 66849, indicating the delivery requirements are geographically confined to this critical military medical facility. Bids must be submitted by August 23, 2026, and the opportunity was posted on August 7, 2026, offering potential vendors a limited window to prepare competitive proposals. There is no designated set-aside category, meaning all eligible contractors may compete, and the contract's success hinges on reliability, speed, and consistent compliance with medical supply standards under high-stress conditions.

Specialized Freight (except Used Goods) Trucking, Local

POSTED

about 20 hours ago

DEADLINE

Routine Bulk Gas Delivery ServicesThe contract outlines the scheduled delivery of liquid oxygen to Landstuhl Regional Medical Center under a subcontract for routine bulk gas services, with all transportation conducted by ADR-certified hazardous materials carriers. Deliveries must adhere strictly to both the U.S.-Germany Status of Forces Agreement and applicable German host-nation regulations to ensure compliance with international and local hazardous material handling protocols. The performance location is specified as Landstuhl, Germany, with a ZIP code of 66849, confirming the operational focus on U.S. military medical facilities in the region. The contract falls under NAICS code 484220, indicating it is classified as a transportation service for hazardous materials. It is managed by the Defense Health Agency under the Department of Defense and was posted on August 7, 2026, with a response deadline of August 23, 2026.

Specialized Freight (except Used Goods) Trucking, Local

POSTED

about 20 hours ago

DEADLINE

Bulk Storage Tank Rental and MaintenanceThe contract involves the rental, maintenance, telemetry monitoring, and certification of a single ASME-certified vertical bulk liquid oxygen storage tank located at Landstuhl, Germany, specifically at the Landstuhl Regional Medical Center. Services include ongoing operational support to ensure the tank remains fully functional and compliant with safety and regulatory standards, with telemetry monitoring providing real-time data on tank conditions such as pressure, temperature, and fill levels. Certification activities must align with ASME codes and applicable medical and hazardous material handling regulations to guarantee uninterrupted oxygen supply for critical patient care. Emergency response support is a mandatory component, requiring immediate availability to address leaks, pressure deviations, equipment failures, or other incidents that could threaten facility operations or personnel safety. The contract is structured as a subcontract under the Defense Health Agency, part of the Department of Defense, with a NAICS code of 423830 indicating wholesale trade of medical and dental equipment. Performance is exclusively tied to the Landstuhl location with a ZIP code of 66849, and the solicitation, posted on August 7, 2026, requires proposals to be submitted by August 23, 2026. While no set-aside provisions or point of contact details are specified, the requirement is mission-critical, prioritizing reliability, rapid response, and continuous compliance to support medical operations in a high-demand military healthcare environment.

Industrial Machinery and Equipment Merchant Wholesalers

POSTED

about 20 hours ago

DEADLINE

Medical Bulk Liquid Oxygen SupplyThe contract pertains to the supply of medicinal-grade liquid oxygen with a minimum purity of 99.5%, meeting stringent pharmacopeial standards including USP, DAB, and EUAB. The oxygen must be delivered FOB destination to Landstuhl Regional Medical Center with the zip code 66849, ensuring seamless integration into the medical facility’s clinical operations. Automatic refill triggers are mandated to maintain uninterrupted supply, eliminating the risk of stockouts during critical patient care scenarios. The contract is classified as a subcontract under NAICS code 325120 and is issued by the Defense Health Agency under the Department of Defense. The solicitation was posted on August 7, 2026, with responses due by August 23, 2026, and performance is concentrated at the specified medical facility in Landstuhl.

Industrial Gas Manufacturing

POSTED

about 20 hours ago

DEADLINE

Battlefield Medical Diagnostics and DevicesThe contract seeks the development of portable, rapid diagnostic tools specifically designed for use in pre-hospital military environments, aiming to enable immediate medical assessment and decision-making on the battlefield. These devices must be rugged, easy to use under extreme conditions, and capable of delivering accurate diagnostic results without reliance on laboratory infrastructure, supporting frontline medics and combat lifesavers in time-critical scenarios. The technology is expected to address gaps in battlefield triage and early detection of trauma, infection, or chemical exposure, with an emphasis on minimal training requirements and compatibility with existing military medical protocols. The contract is classified as a subcontract under NAICS code 339112, indicating a focus on medical and surgical instrument manufacturing, and is managed by the Defense Health Agency within the Department of Defense. The place of performance is centered in Frederick, and interested parties must submit responses by October 30, 2026. While no set-aside provisions are specified, the requirement targets innovative solutions that can be rapidly integrated into field operations, with performance expectations aligned to mission-critical readiness and reliability standards. Technical proposals must demonstrate feasibility, scalability, and the ability to function reliably in austere and high-stress environments.

Surgical and Medical Instrument Manufacturing

POSTED

about 20 hours ago

DEADLINE

Regenerative Medicine for Tissue RepairThe contract titled Regenerative Medicine for Tissue Repair is a subcontract issued by the Defense Health Agency under the Department of Defense to advance research into regenerative therapies aimed at accelerating tissue repair in combat-related injuries. The focus is on innovative approaches such as stem cell applications and biomaterials designed to restore function and reduce recovery time for severe battlefield trauma. The opportunity was posted on August 7, 2026, with a response deadline of October 30, 2026, at 4:00 PM, providing potential applicants a limited window to submit proposals. The North American Industry Classification System code 541715 indicates this effort falls under research and development in the life sciences, specifically in the biomedical field. Performance of the work is expected to be conducted in Frederick, Maryland, aligning with existing military and medical research infrastructure in the region. This subcontract represents a strategic Department of Defense initiative to bridge cutting-edge medical science with urgent battlefield medical needs.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

about 20 hours ago

DEADLINE

High-Priority Pathogen Infection PreventionThe contract seeks preventive solutions non-vaccine approaches to combat infections caused by high-priority pathogens including Pseudomonas aeruginosa and Shigella, targeting urgent public health and defense-related threats. It is issued under the Defense Health Agency within the Department of Defense and is classified as a subcontract, with the North American Industry Classification System code 325412 indicating focus on pharmaceutical preparation manufacturing. The initiative aims to advance innovative, non-pharmaceutical interventions such as antimicrobial barriers, prophylactic agents, or environmental controls that interrupt transmission or reduce pathogen load without relying on vaccines. Responses are due by October 30, 2026, and the performance location is designated as Frederick, though the full address and point of contact details are not provided. The solicitation remains open to qualified entities capable of delivering scalable, evidence-based preventive technologies aligned with military and civilian health protection needs.

Pharmaceutical Preparation Manufacturing

POSTED

about 20 hours ago

DEADLINE

Mental Health Help-Seeking Barrier ReductionThe contract seeks the development of innovative tools, programs, or technologies aimed at reducing stigma and promoting early mental health intervention among military service members. Focused on removing barriers to care, the initiative requires solutions that are practical, scalable, and tailored to the unique culture and operational demands of the armed forces. The work is intended to improve mental health outcomes by increasing awareness, encouraging help-seeking behaviors, and integrating support systems into everyday military life. Submitted under the NAICS code 621340, which pertains to mental health and substance abuse centers, this subcontract is managed by the Defense Health Agency under the Department of Defense. Proposals must be submitted by October 30, 2026, with performance expected to center on Frederick, Maryland. The effort aligns with broader DoD priorities to enhance readiness through proactive mental health support, demanding solutions that are evidence-based, culturally competent, and capable of measuring real-world impact on service member wellbeing.

Offices of Physical, Occupational and Speech Therapists, and Audiologists

POSTED

about 20 hours ago

DEADLINE

Musculoskeletal Injury Treatment OptimizationThe contract seeks innovative prototypes aimed at enhancing the treatment, recovery, and rehabilitation of musculoskeletal injuries frequently experienced by military personnel. Focused on practical, scalable solutions, the initiative targets advancements in medical technology or therapeutic methods that can improve outcomes for service members, with an emphasis on real-world applicability within military healthcare settings. The work is to be performed in Frederick, and the project is categorized under NAICS code 339112, indicating a focus on medical equipment and supplies manufacturing. This is a subcontract opportunity issued by the Defense Health Agency under the Department of Defense, with proposals due by October 30, 2026, and the opportunity was posted on August 7, 2026. There is no set-aside designation specified, and the contract is open to qualified subcontractors capable of delivering advanced, evidence-based solutions tailored to the unique physical demands and recovery needs of military personnel.

Surgical and Medical Instrument Manufacturing

POSTED

about 20 hours ago

DEADLINE

Anesthesia Solutions for Austere EnvironmentsThe contract seeks the development of safe, portable anesthesia delivery systems tailored for use in austere battlefield environments or Role 1 and Role 2 medical settings, where traditional medical infrastructure is limited or unavailable. The focus is on creating reliable, compact, and easy-to-operate anesthesia equipment that ensures patient safety and consistent delivery of anesthetic agents under challenging conditions, including extreme temperatures, power limitations, and high-stress operational scenarios. The solution must prioritize portability, durability, and rapid deployment without compromising clinical efficacy or reducing the need for highly specialized personnel during use. Submitted proposals must align with the NAICS code 339112, indicating a focus on medical equipment and supplies manufacturing, and are expected to meet rigorous military and medical standards for performance and safety. The opportunity is structured as a subcontract, with responses due by October 30, 2026, and performance expected to center around Frederick, Maryland. The Defense Health Agency within the Department of Defense is managing the solicitation with the goal of enhancing medical readiness and sustaining care capabilities in forward-deployed and resource-constrained environments. There is no set-aside designation specified, and while no point of contact is listed, interested parties are directed to the provided SAM.gov link for further details and submission requirements.

Surgical and Medical Instrument Manufacturing

POSTED

about 20 hours ago

DEADLINE

Pathogen-Agnostic Sepsis CountermeasuresThe contract centers on the research and prototype development of pathogen-agnostic countermeasures for sepsis, targeting treatments or diagnostics effective against multiple infectious agents including Pseudomonas aeruginosa and Shigella. This initiative seeks to identify novel therapeutic or diagnostic platforms that function independently of the specific causative pathogen, addressing the critical challenge of sepsis management in heterogeneous infection scenarios. The work is funded under a subcontract arrangement by the Defense Health Agency within the Department of Defense, reflecting a strategic focus on advancing military and civilian medical readiness through innovative biomedical solutions. The project is tied to NAICS code 541715, categorizing it under research and development in the physical, engineering, and life sciences. The opportunity was posted on August 7, 2026, with a response deadline of October 30, 2026, and the performance location is designated as Frederick. While no set-aside provisions or point of contact details are provided, the emphasis on broad-spectrum effectiveness underscores the need for scalable, broadly applicable technologies that can rapidly respond to complex, multi-pathogen sepsis cases. The contract aims to accelerate the transition from concept to prototype, prioritizing solutions with the potential for immediate deployment in clinical and operational settings.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

about 20 hours ago

DEADLINE

Blast Exposure and Traumatic Brain Injury (TBI) SensorsThe contract seeks the design and development of wearable or deployable sensors capable of monitoring blast exposure and providing real-time assessment of traumatic brain injury risk. The goal is to create advanced sensor systems that can detect and quantify blast events, translate the data into actionable physiological indicators, and offer immediate feedback to personnel and medical teams to support rapid intervention and clinical decision-making. These sensors must be suitable for use in operational environments, durable under extreme conditions, and capable of integration with existing military personnel systems. The effort is classified as a subcontract under NAICS code 334510, relating to semiconductor and other electronic component manufacturing, and is managed by the Defense Health Agency under the Department of Defense. Proposals must be submitted by October 30, 2026, with performance expected to take place in Frederick. The solicitation does not specify a set-aside status or point of contact, and the technical requirements emphasize innovation in sensor technology, data accuracy, real-time processing, and field readiness for use by military personnel exposed to blast hazards.

Electromedical and Electrotherapeutic Apparatus Manufacturing

POSTED

about 20 hours ago

DEADLINE

Infectious Disease Vaccine Development | CLEATUS